Rahman, M.; Irmler, M.; Keshavan, S.; Introna, M.; Beckers, J.; Palmberg, L.; Johanson, G.; Ganguly, K.; Upadhyay, S.
Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity. Viruses 2021, 13, 2537.
https://doi.org/10.3390/v13122537
AMA Style
Rahman M, Irmler M, Keshavan S, Introna M, Beckers J, Palmberg L, Johanson G, Ganguly K, Upadhyay S.
Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity. Viruses. 2021; 13(12):2537.
https://doi.org/10.3390/v13122537
Chicago/Turabian Style
Rahman, Mizanur, Martin Irmler, Sandeep Keshavan, Micol Introna, Johannes Beckers, Lena Palmberg, Gunnar Johanson, Koustav Ganguly, and Swapna Upadhyay.
2021. "Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity" Viruses 13, no. 12: 2537.
https://doi.org/10.3390/v13122537
APA Style
Rahman, M., Irmler, M., Keshavan, S., Introna, M., Beckers, J., Palmberg, L., Johanson, G., Ganguly, K., & Upadhyay, S.
(2021). Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity. Viruses, 13(12), 2537.
https://doi.org/10.3390/v13122537